Essential Cases in Head and Neck Oncology. Группа авторов

in oropharyngeal carcinoma: therapeutic implications for the N0 neck. Laryngoscope 116: 1148–1152. https://doi.org/10.1097/01.mlg.0000217543.40027.1d.

      12 Lydiatt, W.M., Patel, S.G., O'Sullivan, B. et al. (2017). Head and neck cancers – major changes in the American Joint Committee on Cancer Eighth Edition Cancer Staging Manual. CA Cancer J. Clin. 67: 122–137.

      13 Mehanna, H., Robinson, M., Hartley, A. et al. (2019). Radiotherapy plus cisplatin or cetuximab in low‐risk human papillomavirus‐positive oropharyngeal cancer (De‐ESCALaTE HPV): an open‐label randomized controlled phase 3 trial. Lancet 393 (10166): 51–60.

      14 Mehta, V., Johnson, P., Tassler, A. et al. (2013). A new paradigm for the diagnosis and management of unknown primary tumors of the head and neck: a role for transoral robotic surgery. Laryngoscope 123: 146–151.

      15 Nichols, A.C., Kneuertz, P.J., Deschler, D.G. et al. (2011). Surgical salvage of the oropharynx after failure of organ‐sparing therapy. Head Neck 33 (4): 516–524.

      16 Pignon, J.P., le Maître, A., Maillard, E., and Bourhis, J. (2009). MACH‐NC collaborative group. Radiother. Oncol. 92 (1): 4–14.

      17 Pilouze, P., Peron, J., Poupart, M. et al. (2017). Salvage surgery for oropharyngeal squamous cell carcinoma: a retrospective study from 2005 to 2013. Head Neck 39: 1744–1750.

      18 Pollei, T.R., Hinni, M.L., Moore, E.J. et al. (2013). Analysis of post‐operative bleeding and risk factors in transoral surgery of the oropharynx. JAMA Otolaryngol. Head Neck Surg. 139 (11): 1212–1218.

      19 Pynnonen, M.A., Gillespie, M.B., Roman, B. et al. (2017). Clinical practice guideline: evaluation of the neck mass in adults. Otolaryngol. Head Neck Surg. 157 (2S): S1–S30.

      20 Sinha, P., Karadaghy, O.A., Doering, M.M. et al. (2018). Survival for HPV‐positive oropharyngeal squamous cell carcinoma with surgical versus non‐surgical treatment approach: a systematic review and meta‐analysis. Oral Oncol. 86: 121–131.

      21 Szturz, P., Wouters, K., Kiyota, N. et al. (2017). Weekly low‐dose versus three‐weekly high‐dose cisplatin for concurrent chemoradiation in locoregionally advanced non‐nasopharyngeal head and neck cancer: a systematic review and meta‐analysis of aggregate data. Oncologist 22 (9): 1056–1066.

      22 White, H., Ford, S., Bush, B. et al. (2013). Salvage surgery for recurrent cancers of the oropharynx comparing TORS with standard open surgical approaches. JAMA Otolaryngol. Head Neck Surg. 139 (8): 773–778.

      23 Zafereo, M.E., Hanasono, M.M., Rosenthal, D.I. et al. (2009). The role of salvage surgery in patients with recurrent squamous cell carcinoma of the oropharynx. Cancer 115 (24): 5723–5733.